Bio-Rad Laboratories (BIO-B) Short term Debt (2009 - 2010)
Bio-Rad Laboratories (BIO-B) reported Short term Debt of $731.1 million for Q4 2010, down 0.92% year-over-year from $737.9 million in Q4 2009, and down 0.92% quarter-over-quarter from $737.9 million in Q4 2009.
Bio-Rad Laboratories (BIO-B) Short term Debt (2009 - 2010) Analysis & Trends
Bio-Rad Laboratories (BIO-B) has 2 years of Short term Debt data on file, last reported at $731.1 million in Q4 2010.
- Short term Debt for Q4 2010 came in at $731.1 million, down 0.92% year-over-year; the trailing twelve-month figure through Dec 2010 was $731.1 million (down 0.92% YoY), and the FY2010 annual result was $731.1 million, down 0.92% from the prior year.
- Short term Debt declined to $731.1 million in Q4 2010 per BIO-B's latest filing, from $737.9 million in the prior quarter.
- Over five years, Short term Debt peaked at $737.9 million in Q4 2009 and troughed at $731.1 million in Q4 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Bio-Rad Laboratories | - | - | 309.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 731.10 Mn |
| Dec 31, 2009 | 737.92 Mn |